Margaret A. Foley

Suggest Changes
Learn More
PURPOSE Epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitors have proven efficacy in advanced non-small-cell lung cancer (NSCLC). We hypothesized that erlotinib would be efficacious in(More)
  • 1